Clinical trials
Hypercholesterolemia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
378 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 2 |
| 2002 | 13 |
| 2003 | 8 |
| 2004 | 9 |
| 2005 | 14 |
| 2006 | 14 |
| 2007 | 19 |
| 2008 | 21 |
| 2009 | 15 |
| 2010 | 11 |
| 2011 | 23 |
| 2012 | 28 |
| 2013 | 27 |
| 2014 | 9 |
| 2015 | 8 |
| 2016 | 20 |
| 2017 | 17 |
| 2018 | 12 |
| 2019 | 6 |
| 2020 | 7 |
| 2021 | 16 |
| 2022 | 11 |
| 2023 | 12 |
| 2024 | 18 |
| 2025 | 12 |
| 2026 | 13 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 295 |
| Terminated | 23 |
| Recruiting | 22 |
| Withdrawn | 10 |
| Unknown status | 9 |
| Active, not recruiting | 9 |
| Enrolling by invitation | 5 |
| Not yet recruiting | 4 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 24 |
| Sanofi | 22 |
| Esperion Therapeutics, Inc. | 15 |
| Novartis Pharmaceuticals | 13 |
| AstraZeneca | 12 |
| Regeneron Pharmaceuticals | 12 |
| National Heart, Lung, and Blood Institute (NHLBI) | 11 |
| Pfizer | 11 |
| Takeda | 10 |
| Merck Sharp & Dohme LLC | 9 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypercholesterolemia | 378 |
| Hyperlipidemias | 70 |
| Dyslipidemias | 54 |
| Hypertension | 52 |
| Diabetes Mellitus | 44 |
| Cardiovascular Diseases | 36 |
| Atherosclerosis | 32 |
| Obesity | 31 |
| Hyperlipoproteinemia Type II | 26 |
| Lipid Metabolism Disorders | 14 |
Trials
Showing 1 to 25 of 378. Each trial links to its page on Pharma Observatory.
278 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.